Schedule 13G ownership disclosure

NEWAMSTERDAM PHARMA COMPANY

Security class unavailable · CUSIP: N62509109

Event date: 2024-08-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-206196
Form type
SC 13G/A
Filer
AMGEN INC
CIK
CIK 318154
Filed
Aug 23, 2024
Reporting period
Aug 22, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub